Suboptimal vaccination coverage of recommended vaccines among French children with recurrent autoinflammatory fever syndromes: a study from the Juvenile Inflammatory Rheumatism cohort.
Familial Mediterranean fever
Periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome
Recurrent autoinflammatory fever syndromes
Systemic autoinflammatory diseases
Undefined recurrent fever
Vaccination coverage
Journal
Clinical rheumatology
ISSN: 1434-9949
Titre abrégé: Clin Rheumatol
Pays: Germany
ID NLM: 8211469
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
received:
05
10
2020
accepted:
16
12
2020
revised:
08
12
2020
pubmed:
14
1
2021
medline:
12
6
2021
entrez:
13
1
2021
Statut:
ppublish
Résumé
To determine vaccination coverage among a French cohort of children with recurrent autoinflammatory fever syndromes (RFS). All RFS children aged 2 to 19 years from the Juvenile Inflammatory Rheumatism cohort and followed at the French Reference Center for Autoinflammatory Diseases, Versailles Hospital, were included in our observational study. Immunisation status at ages 2, 7 and 15 years and at the last outpatient visit was evaluated according to the standard French vaccine schedule and recommended supplementary vaccines for patients with immunosuppressive therapy. Of 200 patients, 90 (45%) had periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome; 52 (26%) had familial Mediterranean fever and 50 (25%) had undefined recurrent fever. Complete immunisation as per the standard schedule was obtained by 32% of patients at 2 years, 28% at 7 years, 6% at 15 years and 44% at the last outpatient visit. Similar or higher coverage was obtained by the last outpatient visit for most vaccines, compared to immunisation coverage at 2 years: pneumococcus (91% vs 88%), diphtheria tetanus poliomyelitis (82% vs 86%), hepatitis B (79% vs 69%) and measles, mumps, rubella (91% vs 50%). No patients with immunosuppressive therapy (n = 14) were up to date for all supplementary immunisations recommended for them. Vaccination coverage for RFS children is suboptimal, especially for infants who present with recurrent febrile episodes. The initial vaccination delay is partially corrected through specialist follow-up in later years. Coverage according to the supplementary vaccine recommendations for immunosuppressed patients is poor. Key Points • Vaccination coverage for RFS children is suboptimal, especially at 2 years of age which is likely due to the prevalence of early recurrent febrile symptoms. • The initial vaccination delay is partially recovered during later follow-up at an expert rheumatology center. • Specific recommendations are particularly difficult to apply to patients on immunosuppressive therapy.
Identifiants
pubmed: 33439385
doi: 10.1007/s10067-020-05553-y
pii: 10.1007/s10067-020-05553-y
doi:
Substances chimiques
Vaccines
0
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
2855-2864Références
Grateau G, Hentgen V, Stojanovic KS, Jéru I, Amselem S, Steichen O (2013) How should we approach classification of autoinflammatory diseases? Nat Rev Rheumatol 9:624–629. https://doi.org/10.1038/nrrheum.2013.101
doi: 10.1038/nrrheum.2013.101
pubmed: 23838615
Shoenfeld Y, Agmon-Levin N (2011) “ASIA” - autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun 36:4–8. https://doi.org/10.1016/j.jaut.2010.07.003
doi: 10.1016/j.jaut.2010.07.003
pubmed: 20708902
Dell’ Era L, Esposito S, Corona F, Principi N (2011) Vaccination of children and adolescents with rheumatic diseases. Rheumatol Oxf Engl 50:1358–1365. https://doi.org/10.1093/rheumatology/ker102
doi: 10.1093/rheumatology/ker102
Walker UA, Hoffman HM, Williams R, Kuemmerle-Deschner J, Hawkins PN (2016) Brief report: severe inflammation following vaccination against Streptococcus pneumoniae in patients with cryopyrin-associated periodic syndromes. Arthritis Rheumatol Hoboken NJ 68:516–520. https://doi.org/10.1002/art.39482
doi: 10.1002/art.39482
Kang I (2016) Editorial: is the NLPR3 inflammasome “overheated” by pneumococcal vaccination in cryopyrin-associated periodic syndromes? Arthritis Rheumatol Hoboken NJ 68:274–276. https://doi.org/10.1002/art.39483
doi: 10.1002/art.39483
Hügle T, Bircher A, Walker UA (2012) Streptococcal hypersensitivity reloaded: severe inflammatory syndrome in Behcet’s disease following 23-valent polysaccharide Streptococcus pneumoniae vaccine. Rheumatol Oxf Engl 51:761–762. https://doi.org/10.1093/rheumatology/ker388
doi: 10.1093/rheumatology/ker388
Kraszewska-Głomba B, Matkowska-Kocjan A, Miśkiewicz K, Szymańska-Toczek Z, Wójcik M, Banyś D, Szenborn L (2016) Mumps, measles and rubella vaccination in children with PFAPA syndrome. Vaccine 34:5903–5906. https://doi.org/10.1016/j.vaccine.2016.10.035
doi: 10.1016/j.vaccine.2016.10.035
pubmed: 27997341
Bodar EJ, van der Hilst JCH, Drenth JPH, van der Meer J, Simon A (2005) Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model. Neth J Med 63:260–264
pubmed: 16093577
Jaeger VK, Hoffman HM, van der Poll T, Tilson H, Seibert J, Speziale A, Junge G, Franke K, Vritzali E, Hawkins PN, Kuemmerle-Deschner J, Walker UA (2017) Safety of vaccinations in patients with cryopyrin-associated periodic syndromes: a prospective registry based study. Rheumatol Oxf Engl 56:1484–1491. https://doi.org/10.1093/rheumatology/kex185
doi: 10.1093/rheumatology/kex185
Infanrix hexa : summary of product characteristics. Available on https://www.ema.europa.eu/en/documents/product-information/infanrix-hexa-epar-product-information_en.pdf
Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V (2006) Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295:2275–2285. https://doi.org/10.1001/jama.295.19.2275
doi: 10.1001/jama.295.19.2275
pubmed: 16705109
Doran MF, Crowson CS, Pond GR, O’Fallon WM, Gabriel SE (2002) Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 46:2287–2293. https://doi.org/10.1002/art.10524
doi: 10.1002/art.10524
pubmed: 12355475
Beukelman T, Xie F, Chen L, Baddley JW, Delzell E, Grijalva CG, Lewis JD, Ouellet-Hellstrom R, Patkar NM, Saag KG, Winthrop KL, Curtis JR, on behalf of the SABER Collaboration (2012) Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment. Arthritis Rheum 64:2773–2780. https://doi.org/10.1002/art.34458
doi: 10.1002/art.34458
pubmed: 22569881
pmcid: 3409300
Beukelman T, Xie F, Baddley JW, Chen L, Delzell E, Grijalva CG, Mannion ML, Patkar NM, Saag KG, Winthrop KL, Curtis JR, on behalf of the SABER Collaboration (2013) Brief report: incidence of selected opportunistic infections among children with juvenile idiopathic arthritis. Arthritis Rheum 65:1384–1389. https://doi.org/10.1002/art.37866
doi: 10.1002/art.37866
pubmed: 23460423
pmcid: 3636167
De Pieri C, Taddio A, Insalaco A et al (2015) Different presentations of mevalonate kinase deficiency: a case series. Clin Exp Rheumatol 33:437–442
pubmed: 25897835
Berody S, Galeotti C, Koné-Paut I, Piram M (2015) A restrospective survey of patients’s journey before the diagnosis of mevalonate kinase deficiency. Joint Bone Spine 82:240–244. https://doi.org/10.1016/j.jbspin.2014.12.011
doi: 10.1016/j.jbspin.2014.12.011
pubmed: 25677409
Heijstek MW, Ott de Bruin LM, Borrow R, van der Klis F, Koné-Paut I, Fasth A, Minden K, Ravelli A, Abinun M, Pileggi G, Borte M, Bijl M, Wulffraat NM (2011) Vaccination in paediatric patients with auto-immune rheumatic diseases: a systemic literature review for the European League against Rheumatism evidence-based recommendations. Autoimmun Rev 11:112–122. https://doi.org/10.1016/j.autrev.2011.08.010
doi: 10.1016/j.autrev.2011.08.010
pubmed: 21896342
Heijstek MW, Ott de Bruin LM, Bijl M, Borrow R, van der Klis F, Koné-Paut I, Fasth A, Minden K, Ravelli A, Abinun M, Pileggi GS, Borte M, Wulffraat NM (2011) EULAR recommendations for vaccination in paediatric patients with rheumatic diseases. Ann Rheum Dis 70:1704–1712. https://doi.org/10.1136/ard.2011.150193
doi: 10.1136/ard.2011.150193
pubmed: 21813547
Groot N, Heijstek MW, Wulffraat NM (2015) Vaccinations in paediatric rheumatology: an update on current developments. Curr Rheumatol Rep 17:46. https://doi.org/10.1007/s11926-015-0519-y
doi: 10.1007/s11926-015-0519-y
pubmed: 26025339
pmcid: 4449376
Sousa S, Duarte AC, Cordeiro I, Ferreira J, Gonçalves MJ, Meirinhos T, Rocha TM, Romão VC, Santos MJ (2017) Efficacy and safety of vaccination in pediatric patients with systemic inflammatory rheumatic diseases: a systematic review of the literature. Acta Reumatol Port 42:8–16
pubmed: 28133957
Diallo D, Santal C, Lagrée M, Martinot A, Dubos F (2020) Vaccination coverage of children with chronic diseases is inadequate especially for specifically recommended vaccines. Acta Paediatr Oslo Nor:1992. https://doi.org/10.1111/apa.15275
Garcia-Fernandez de Villalta M, Mellado-Peña MJ, Delgado-Hierro A, Limia-Sanchez A, Climent-Alcala FJ, Escosa-Garcia L, Rodriguez-Alonso A, Calvo C, Mendez-Echevarria A (1992) Greater efforts are needed to ensure that children with complex medical conditions are properly vaccinated. Acta Paediatr Oslo Nor 2020(109):422–423. https://doi.org/10.1111/apa.15042
doi: 10.1111/apa.15042
Morin M-P, Quach C, Fortin E, Chédeville G (2012) Vaccination coverage in children with juvenile idiopathic arthritis followed at a paediatric tertiary care Centre. Rheumatol Oxf Engl 51:2046–2050. https://doi.org/10.1093/rheumatology/kes175
doi: 10.1093/rheumatology/kes175
Bizjak M, Blazina Š, Zajc Avramovič M et al (2020) Vaccination coverage in children with rheumatic diseases. Clin Exp Rheumatol 38:164–170
pubmed: 31577215
Gattorno M, Hofer M, Federici S, Vanoni F, Bovis F, Aksentijevich I, Anton J, Arostegui JI, Barron K, Ben-Cherit E, Brogan PA, Cantarini L, Ceccherini I, de Benedetti F, Dedeoglu F, Demirkaya E, Frenkel J, Goldbach-Mansky R, Gul A, Hentgen V, Hoffman H, Kallinich T, Kone-Paut I, Kuemmerle-Deschner J, Lachmann HJ, Laxer RM, Livneh A, Obici L, Ozen S, Rowczenio D, Russo R, Shinar Y, Simon A, Toplak N, Touitou I, Uziel Y, van Gijn M, Foell D, Garassino C, Kastner D, Martini A, Sormani MP, Ruperto N, Eurofever Registry and the Paediatric Rheumatology International Trials Organisation (PRINTO) (2019) Classification criteria for autoinflammatory recurrent fevers. Ann Rheum Dis 78:1025–1032. https://doi.org/10.1136/annrheumdis-2019-215048
doi: 10.1136/annrheumdis-2019-215048
pubmed: 31018962
Health Ministry. 2018 French vaccine calendar https://www.mesvaccins.net/textes/calendrier_vaccinations_2018_MVN.pdf
Haut Conseil de Santé Publique (2014). Vaccination des personnes immunodéprimées ou aspléniques. Recommandations. Disponible sur https://www.hcsp.fr
Mesure de la couverture vaccinale en France. Sources de données et données actuelles.Institut de Veille Sanitaire. https://www.santepubliquefrance.fr/determinants-de-sante/vaccination/donnees . Accessed 11 Jan 2021
Stahl J-P, Cohen R, Denis F, Gaudelus J, Lery T, Lepetit H, Martinot A (2013) Vaccination against meningococcus C. vaccinal coverage in the French target population. Med Mal Infect 43:75–80. https://doi.org/10.1016/j.medmal.2013.01.001
doi: 10.1016/j.medmal.2013.01.001
pubmed: 23428390
Georgin-Lavialle S, Fayand A, Rodrigues F, Bachmeyer C, Savey L, Grateau G (2019) Autoinflammatory diseases: state of the art. Presse Medicale Paris Fr 1983 48:e25–e48. https://doi.org/10.1016/j.lpm.2018.12.003
doi: 10.1016/j.lpm.2018.12.003
Bailly A-C, Gras P, Lienhardt J-F, Requillart JC, Vié-le-Sage F, Martinot A, Dubos F (2018) Timeliness of vaccination in infants followed by primary-care pediatricians in France. Hum Vaccines Immunother 14:1018–1023. https://doi.org/10.1080/21645515.2017.1409318
doi: 10.1080/21645515.2017.1409318
Le Maréchal M, Fressard L, Raude J et al (2018) General practitioners and vaccination of children presenting with a benign infection. Med Mal Infect 48:44–52. https://doi.org/10.1016/j.medmal.2017.09.018
doi: 10.1016/j.medmal.2017.09.018
pubmed: 29113691
Askew GL, Finelli L, Lutz J et al (1995) Beliefs and practices regarding childhood vaccination among urban pediatric providers in New Jersey. Pediatrics 96:889–892
pubmed: 7478831
Rey D, Fressard L, Cortaredona S et al (2018) Vaccine hesitancy in the French population in 2016, and its association with vaccine uptake and perceived vaccine risk-benefit balance. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull 23. https://doi.org/10.2807/1560-7917.ES.2018.23.17.17-00816
Fleurier A, Pelatan C, Willot S, Ginies JL, Breton E, Bridoux L, Segura JF, Chaillou E, Jobert A, Darviot E, Cagnard B, Delaperriere N, Grimal I, Carre E, Wagner AC, Sylvestre E, Dabadie A (2015) Vaccination coverage of children with inflammatory bowel disease after an awareness campaign on the risk of infection. Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver 47:460–464. https://doi.org/10.1016/j.dld.2015.02.009
doi: 10.1016/j.dld.2015.02.009
Harris JG, Maletta KI, Ren B, Olson JC (2015) Improving pneumococcal vaccination in pediatric rheumatology patients. Pediatrics 136:e681–e686. https://doi.org/10.1542/peds.2014-2512
doi: 10.1542/peds.2014-2512
pubmed: 26304825
Doherty M, Schmidt-Ott R, Santos JI, Stanberry LR, Hofstetter AM, Rosenthal SL, Cunningham AL (2016) Vaccination of special populations: protecting the vulnerable. Vaccine 34:6681–6690. https://doi.org/10.1016/j.vaccine.2016.11.015
doi: 10.1016/j.vaccine.2016.11.015
Wiot F, Shirley J, Prugnola A, di Pasquale A, Philip R (2019) Challenges facing vaccinators in the 21st century: results from a focus group qualitative study. Hum Vaccines Immunother 15:2806–2815. https://doi.org/10.1080/21645515.2019.1621147
doi: 10.1080/21645515.2019.1621147
Carlson SJ, Scanlan C, Marshall HS, Blyth CC, Macartney K, Leask J (2019) Attitudes about and access to influenza vaccination experienced by parents of children hospitalised for influenza in Australia. Vaccine 37:5994–6001. https://doi.org/10.1016/j.vaccine.2019.08.021
doi: 10.1016/j.vaccine.2019.08.021
pubmed: 31471153
Hua C, Morel J, Ardouin E, Ricard E, Foret J, Mathieu S, Combe B, Lukas C (2015) Reasons for non-vaccination in French rheumatoid arthritis and spondyloarthritis patients. Rheumatol Oxf Engl 54:748–750. https://doi.org/10.1093/rheumatology/keu531
doi: 10.1093/rheumatology/keu531
Hurley LP, Allison MA, Pilishvili T, O’Leary ST, Crane LA, Brtnikova M, Beaty BL, Lindley MC, Bridges CB, Kempe A (2018) Primary care physicians’ struggle with current adult pneumococcal vaccine recommendations. J Am Board Fam Med JABFM 31:94–104. https://doi.org/10.3122/jabfm.2018.01.170216
doi: 10.3122/jabfm.2018.01.170216
pubmed: 29330244
Wilson MW, Brown BJ, Miles MC (2016) A multicomponent intervention to improve pneumococcal vaccination knowledge among internal medicine residents. MedEdPORTAL J Teach Learn Resour 12:10414. https://doi.org/10.15766/mep_2374-8265.10414
doi: 10.15766/mep_2374-8265.10414